EWTX
Edgewise Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$3.65B
P/E Ratio
—
EPS
$-1.66
Beta
0.30
52W High
$40.77
52W Low
$12.15
50-Day MA
$33.59
200-Day MA
$25.48
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Edgewise Therapeutics Inc
Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The company is headquartered in Boulder, Colorado.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-197.45M |
| Operating Margin | 0.00% |
| Return on Equity | -38.10% |
| Return on Assets | -25.60% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $4.59 |
| Price-to-Book | 7.40 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | -2.60 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $107.59M |
| Float | $67.12M |
| % Insiders | 0.45% |
| % Institutions | 113.97% |
Historical Volatility
HV 10-Day
106.26%
HV 20-Day
78.30%
HV 30-Day
86.29%
HV 60-Day
66.98%
HV Rank
86.9%
Volatility is currently expanding
Analyst Ratings
Consensus ($46.08 target)
3
Strong Buy7
Buy2
HoldMore HEALTHCARE Stocks
Data last updated: 6/13/2026